Looking forward to speaking about our #TB #vaccine and #organoid work at a busy #3Rs event on Wednesday - already 1000 participants registered! 🙌

Imagine a world without mRNA

Tuberculosis is a curable disease, yet millions of people fall ill or die of TB due to antimicrobial resistance. Now a consortium led by Oxford Biology Rachel Tanner 💉 aims to develop new therapies to tackle TB thanks to a £5m grant from Ineos Oxford Institute for Antimicrobial Research bit.ly/4kcGxcL

Do you have Yr12 students in state school interested in studying Biology with us? Balliol College has the event for them. forms.office.com/pages/response…

Massive $200 million TB research programme derailed by US funding cuts spotlightnsp.co.za/2025/03/04/mas…

Modelling on potential impact of Tuberculosis globally shows the US funding cuts would result in 2.2 million additional TB deaths and 10.6 million additional TB cases during 2025-30. A Deadly Equation: The Global Toll of US TB Funding Cuts | medRxiv Stop TB Partnership Suvanand Sahu

Latest research published by South African Tuberculosis Vaccine Initiative reporting results from the Phase 2a MTBVAC TB Vaccine trial study conducted appearing in the eBioMedicine – The Lancet Discovery Science. UCT IDM UCT Health Sciences Carlos Martin sciencedirect.com/science/articl…

Our Vaccine Engagement Day is on 26 March 2025! Let's #CelebrateVaccines to strengthen public understanding and empower informed decisions about vaccines 🎉 Get involved by posting on social media to highlight the successes of vaccines! 🌟 bit.ly/3Rasp6s

Free online Q&A on writing non-fiction with bestselling author Angela Saini! 30th April, from Spread the Word spreadtheword.org.uk/events/angela-…

TWO postdoc positions in Computational Microbiology and/or biochemistry. Join our interdisciplinary group in the new Life and Mind Building Oxford Biology, University of Oxford, Ineos Oxford Institute for Antimicrobial Research Please apply and share this post: jobs.ac.uk/job/DMP641/pos…

We're recruiting! Looking for an experienced and motivated #postdoctoral researcher to join the #TannerLab as part of our Ineos Oxford Institute for Antimicrobial Research funded consortium for the development of new #TB #drugs 🫁💊 my.corehr.com/pls/uoxrecruit…

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial - The Lancet Global Health thelancet.com/journals/langl…

Wondering how #BCG #vaccination confers protection against unrelated #pathogens? 💉🦠 Of course you are! Check out our new #SystematicReview on #immune mechanisms underlying #heterologous protection, led by very talented Med student Louis Torracinta: frontiersin.org/journals/immun…

Are you interested in #TB and have experience in #modelling infectious diseases? Come join us in the fun, supportive, and world-leading TB Modelling Group at London School of Hygiene & Tropical Medicine ! We have a 1 year Research Fellow position (with possible extension) Closing date of 30 May 2025 👉

It was my pleasure to be interviewed by The Immunology in Africa Podcast for this episode of Immunology to TB. Here I share my journey as a scientist and our contributions to TB vaccine development.

New #MGIA paper in collaboration with UCT 🇿🇦 onlinelibrary.wiley.com/doi/10.1111/im… Poorer control of mycobacterial growth following #BCG #vaccination administered during an acute malarial infection compared to BCG only or BCG after blood-stage #malaria infection 💉🦟🩸

This should be required reading by all graduate students and postdocs | A brief guide to statistical analysis of grouped data in preclinical research nature.com/articles/s4225…

New paper: سالم بن سلمان Salem identified new #Mtb antigens using #immunopeptidomics, screened them using #MGIA, identified metE as promising, & confirmed in murine challenge studies 🤩 A potential new #TB #vaccine candidate in the making 💉 Congrats Salem! 👏 frontiersin.org/journals/immun…

Journals can’t find peer reviewers. Preprints aren’t taken seriously. Garbage papers slip through peer review. Meantime, AI is slowly taking over. Nature describes the current situation. I highly recommend reading the article. 📍 The summary (+ my comments): 1. We are facing a